Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 70,849 | 302 | 314 | 1,772 | 2,963 |
| Gross Profit | 70,849 | 302 | 314 | 1,772 | 2,963 |
| Operating Expenses | 434,244 | 299,337 | 254,764 | 136,076 | 82,691 |
| Operating Income | -363,395 | -299,035 | -254,450 | -134,304 | -79,728 |
| Interest Expense | 4,948 | 2,197 | 1,331 | 486 | 3 |
| Other Income | 25,742 | 31,283 | 18,047 | 4,916 | 318 |
| Pre-tax Income | -342,601 | -269,949 | -237,734 | -129,874 | -79,413 |
| Net Income Continuous | -342,601 | -269,949 | -237,734 | -129,874 | -79,413 |
| Net Income | $-342,601 | $-269,949 | $-237,734 | $-129,874 | $-79,413 |
| EPS Basic Total Ops | -3.32 | -3.07 | -3.91 | -2.71 | -6.66 |
| EPS Basic Continuous Ops | -4.04 | -3.98 | -5.31 | -4.05 | -6.66 |
| EPS Diluted Total Ops | -3.32 | -3.07 | -3.91 | -2.71 | -6.66 |
| EPS Diluted Continuous Ops | -4.04 | -3.98 | -5.31 | -4.05 | -6.66 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.07 | -5.31 | -4.05 | -6.68 |
| EBITDA(a) | $-369,693 | $-314,150 | $-265,418 | $-134,259 | $-78,643 |